vs

Side-by-side financial comparison of BigBear.ai Holdings, Inc. (BBAI) and BICYCLE THERAPEUTICS PLC (BCYC). Click either name above to swap in a different company.

BICYCLE THERAPEUTICS PLC is the larger business by last-quarter revenue ($48.0M vs $27.3M, roughly 1.8× BigBear.ai Holdings, Inc.). On growth, BICYCLE THERAPEUTICS PLC posted the faster year-over-year revenue change (1193.3% vs -37.7%). BICYCLE THERAPEUTICS PLC produced more free cash flow last quarter ($-19.9M vs $-22.1M). Over the past eight quarters, BICYCLE THERAPEUTICS PLC's revenue compounded faster (56.7% CAGR vs -9.2%).

BigBear.ai Holdings, Inc. develops and delivers artificial intelligence-powered decision support and analytics solutions. Its core offerings cover predictive analytics, supply chain optimization, and operational intelligence platforms, serving key segments including national defense, intelligence agencies, and commercial enterprise clients primarily across North America, helping customers improve operational efficiency and mitigate risks.

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.

BBAI vs BCYC — Head-to-Head

Bigger by revenue
BCYC
BCYC
1.8× larger
BCYC
$48.0M
$27.3M
BBAI
Growing faster (revenue YoY)
BCYC
BCYC
+1231.0% gap
BCYC
1193.3%
-37.7%
BBAI
More free cash flow
BCYC
BCYC
$2.2M more FCF
BCYC
$-19.9M
$-22.1M
BBAI
Faster 2-yr revenue CAGR
BCYC
BCYC
Annualised
BCYC
56.7%
-9.2%
BBAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BBAI
BBAI
BCYC
BCYC
Revenue
$27.3M
$48.0M
Net Profit
$-20.2M
Gross Margin
20.3%
Operating Margin
-295.0%
-51.5%
Net Margin
-42.0%
Revenue YoY
-37.7%
1193.3%
Net Profit YoY
61.1%
EPS (diluted)
$0.17
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBAI
BBAI
BCYC
BCYC
Q4 25
$27.3M
$48.0M
Q3 25
$33.1M
$11.7M
Q2 25
$32.5M
$2.9M
Q1 25
$34.8M
$10.0M
Q4 24
$43.8M
$3.7M
Q3 24
$41.5M
$2.7M
Q2 24
$39.8M
$9.4M
Q1 24
$33.1M
$19.5M
Net Profit
BBAI
BBAI
BCYC
BCYC
Q4 25
$-20.2M
Q3 25
$2.5M
$-59.1M
Q2 25
$-228.6M
$-79.0M
Q1 25
$-62.0M
$-60.8M
Q4 24
Q3 24
$-15.1M
$-50.8M
Q2 24
$-14.4M
$-39.8M
Q1 24
$-127.8M
$-26.6M
Gross Margin
BBAI
BBAI
BCYC
BCYC
Q4 25
20.3%
Q3 25
22.4%
Q2 25
25.0%
Q1 25
21.3%
Q4 24
37.4%
Q3 24
25.9%
Q2 24
27.8%
Q1 24
21.1%
Operating Margin
BBAI
BBAI
BCYC
BCYC
Q4 25
-295.0%
-51.5%
Q3 25
-66.0%
-558.6%
Q2 25
-278.1%
-2965.8%
Q1 25
-61.0%
-703.7%
Q4 24
-18.6%
Q3 24
-25.4%
-2385.9%
Q2 24
-41.9%
-498.3%
Q1 24
-296.1%
-162.4%
Net Margin
BBAI
BBAI
BCYC
BCYC
Q4 25
-42.0%
Q3 25
7.6%
-503.7%
Q2 25
-704.0%
-2703.8%
Q1 25
-178.3%
-608.9%
Q4 24
Q3 24
-36.5%
-1898.4%
Q2 24
-36.3%
-425.3%
Q1 24
-385.8%
-136.0%
EPS (diluted)
BBAI
BBAI
BCYC
BCYC
Q4 25
$0.17
$-0.29
Q3 25
$-0.03
$-0.85
Q2 25
$-0.71
$-1.14
Q1 25
$-0.25
$-0.88
Q4 24
$-0.47
Q3 24
$-0.06
$-0.74
Q2 24
$-0.06
$-0.77
Q1 24
$-0.68
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBAI
BBAI
BCYC
BCYC
Cash + ST InvestmentsLiquidity on hand
$87.1M
$628.1M
Total DebtLower is stronger
$107.0M
Stockholders' EquityBook value
$611.9M
$610.0M
Total Assets
$894.5M
$717.6M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBAI
BBAI
BCYC
BCYC
Q4 25
$87.1M
$628.1M
Q3 25
$456.6M
$648.3M
Q2 25
$390.8M
$721.5M
Q1 25
$107.6M
$793.0M
Q4 24
$50.1M
$879.5M
Q3 24
$65.6M
$890.9M
Q2 24
$72.3M
$961.4M
Q1 24
$81.4M
$457.0M
Total Debt
BBAI
BBAI
BCYC
BCYC
Q4 25
$107.0M
Q3 25
$104.9M
Q2 25
$103.0M
Q1 25
$101.4M
Q4 24
$136.2M
Q3 24
$195.7M
Q2 24
$195.7M
$30.9M
Q1 24
$195.6M
$30.8M
Stockholders' Equity
BBAI
BBAI
BCYC
BCYC
Q4 25
$611.9M
$610.0M
Q3 25
$610.0M
$618.5M
Q2 25
$266.6M
$668.9M
Q1 25
$197.8M
$740.3M
Q4 24
$-3.7M
$793.1M
Q3 24
$127.5M
$831.0M
Q2 24
$134.7M
$873.8M
Q1 24
$143.2M
$356.0M
Total Assets
BBAI
BBAI
BCYC
BCYC
Q4 25
$894.5M
$717.6M
Q3 25
$919.8M
$764.0M
Q2 25
$599.4M
$832.2M
Q1 25
$396.3M
$883.9M
Q4 24
$343.8M
$956.9M
Q3 24
$354.1M
$996.7M
Q2 24
$360.9M
$1.1B
Q1 24
$377.6M
$547.1M
Debt / Equity
BBAI
BBAI
BCYC
BCYC
Q4 25
0.17×
Q3 25
0.17×
Q2 25
0.39×
Q1 25
0.51×
Q4 24
Q3 24
1.54×
Q2 24
1.45×
0.04×
Q1 24
1.37×
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBAI
BBAI
BCYC
BCYC
Operating Cash FlowLast quarter
$-21.8M
$-19.3M
Free Cash FlowOCF − Capex
$-22.1M
$-19.9M
FCF MarginFCF / Revenue
-80.9%
-41.5%
Capex IntensityCapex / Revenue
0.9%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M
$-252.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBAI
BBAI
BCYC
BCYC
Q4 25
$-21.8M
$-19.3M
Q3 25
$-9.6M
$-71.2M
Q2 25
$-3.9M
$-72.8M
Q1 25
$-6.7M
$-86.4M
Q4 24
$-14.8M
$-164.7M
Q3 24
$-1.9M
$-39.8M
Q2 24
$-7.1M
$-44.6M
Q1 24
$-14.4M
$-70.9M
Free Cash Flow
BBAI
BBAI
BCYC
BCYC
Q4 25
$-22.1M
$-19.9M
Q3 25
$-9.8M
$-71.8M
Q2 25
$-3.9M
$-73.3M
Q1 25
$-6.7M
$-87.0M
Q4 24
$-15.0M
$-166.0M
Q3 24
$-2.0M
$-40.3M
Q2 24
$-7.2M
$-45.0M
Q1 24
$-14.4M
$-70.9M
FCF Margin
BBAI
BBAI
BCYC
BCYC
Q4 25
-80.9%
-41.5%
Q3 25
-29.5%
-612.3%
Q2 25
-11.9%
-2509.7%
Q1 25
-19.4%
-871.7%
Q4 24
-34.2%
-4475.7%
Q3 24
-4.9%
-1504.7%
Q2 24
-18.1%
-481.2%
Q1 24
-43.5%
-362.9%
Capex Intensity
BBAI
BBAI
BCYC
BCYC
Q4 25
0.9%
1.2%
Q3 25
0.6%
5.7%
Q2 25
0.0%
17.1%
Q1 25
0.2%
6.1%
Q4 24
0.4%
33.3%
Q3 24
0.3%
16.3%
Q2 24
0.3%
4.5%
Q1 24
0.1%
0.1%
Cash Conversion
BBAI
BBAI
BCYC
BCYC
Q4 25
Q3 25
-3.80×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons